Literature DB >> 11079780

Kinin B1 receptor expression and function on human brain endothelial cells.

A Prat1, K Biernacki, S Pouly, J Nalbantoglu, R Couture, J P Antel.   

Abstract

The kinin B1 receptor is an inducible receptor expressed in response to inflammatory mediators. We sought to determine whether kinin B1 receptor can be expressed on human brain endothelial cells (HBECs) in vitro and whether signaling via this receptor can regulate permeability and chemokine production properties of these cells. Multiplex RT-PCR amplification and western blot techniques were used to evaluate B1 receptor expression by HBECs. Although B1 receptor mRNA and protein could not be detected on resting HBECs, interferon-gamma induced a dose- and time-dependent up-regulation of B1 receptor mRNA and protein on HBECs. Stimulation of interferon-gamma-treated HBECs with the selective B1 agonist R-838 (Sar [D-Phe8] des Arg9-BK) induced a dose- and time-dependent increase in the production of inositol 3,4,5 tri-phosphate and nitric oxide. Permeability of the HBECs monolayer, as measured by BSA diffusion, was significantly increased by application of the B1 agonist. This biological effect of R-838 could be prevented by R-715, a B1 receptor antagonist and by L-NAME, a nitric oxide synthase blocker. R-838 also inhibited interleukin-8 release from HBECs. We demonstrate that B1 receptors can be up regulated on the surface of HBECs by molecules released during inflammatory response and that signaling via this receptor can regulate BBB permeability and chemokine production in vitro.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11079780     DOI: 10.1093/jnen/59.10.896

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  20 in total

Review 1.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

2.  Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system.

Authors:  Ulf Schulze-Topphoff; Alexandre Prat; Timour Prozorovski; Volker Siffrin; Magdalena Paterka; Josephine Herz; Ivo Bendix; Igal Ifergan; Ines Schadock; Marcelo A Mori; Jack Van Horssen; Friederike Schröter; Alina Smorodchenko; May Htwe Han; Michael Bader; Lawrence Steinman; Orhan Aktas; Frauke Zipp
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

Review 3.  [Coagulation factors and multiple sclerosis : Key factors in the pathogenesis?]

Authors:  K Göbel; C Kleinschnitz; S G Meuth
Journal:  Nervenarzt       Date:  2018-08       Impact factor: 1.214

4.  Plasma kallikrein modulates immune cell trafficking during neuroinflammation via PAR2 and bradykinin release.

Authors:  Kerstin Göbel; Chloi-Magdalini Asaridou; Monika Merker; Susann Eichler; Alexander M Herrmann; Eva Geuß; Tobias Ruck; Lisa Schüngel; Linda Groeneweg; Venu Narayanan; Tilman Schneider-Hohendorf; Catharina C Gross; Heinz Wiendl; Beate E Kehrel; Christoph Kleinschnitz; Sven G Meuth
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-17       Impact factor: 11.205

5.  B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients.

Authors:  Raphael Schneider; Alma Nazlie Mohebiany; Igal Ifergan; Diane Beauseigle; Pierre Duquette; Alexandre Prat; Nathalie Arbour
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

6.  Predictive value of serum bradykinin and desArg9-bradykinin levels for chemotherapeutic responses in active tuberculosis patients: A retrospective case series.

Authors:  Xu Qian; Duc T M Nguyen; Yaojun Li; Jianxin Lyu; Edward A Graviss; Tony Y Hu
Journal:  Tuberculosis (Edinb)       Date:  2016-09-28       Impact factor: 3.131

Review 7.  Astrocyte-endothelial interactions and blood-brain barrier permeability.

Authors:  N Joan Abbott
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

8.  Modulation of the kallikrein/kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis.

Authors:  A Uzawa; M Mori; J Taniguchi; S Kuwabara
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

9.  The bradykinin B1 receptor regulates Aβ deposition and neuroinflammation in Tg-SwDI mice.

Authors:  Giselle F Passos; Rodrigo Medeiros; David Cheng; Vitaly Vasilevko; Frank M Laferla; David H Cribbs
Journal:  Am J Pathol       Date:  2013-03-05       Impact factor: 4.307

10.  Brain endothelial cell-cell junctions: how to "open" the blood brain barrier.

Authors:  Svetlana M Stamatovic; Richard F Keep; Anuska V Andjelkovic
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.